Literature DB >> 7664644

Agonist-stimulated phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein.

E Blind1, T Bambino, R A Nissenson.   

Abstract

The objectives of the present study were to determine whether the G protein-coupled receptor for PTH and PTH-related protein (PTHrP) is subject to agonist-specific phosphorylation and to characterize the relevant kinase(s). The opossum kidney PTH/PTHrP receptor stably expressed in human embryonic kidney 293 cells was coupled to adenylyl cyclase, with half-maximal activation occurring in the presence of 0.1 nM bovine (b) PTH-(1-34). Immunoprecipitation of extracts of 32P-labeled cells using a monoclonal antibody to the PTH/PTHrP receptor revealed the presence of a major 32P-labeled protein of approximately 85 kilodaltons that was not evident in untransfected 293 cells. bPTH-(1-34) treatment produced a rapid dose-dependent increase in phosphorylation of the 85-kilodalton receptor, with a maximal effect that was 3.5 +/- 0.7-fold (n = 4) over basal. Half-maximal phosphorylation occurred with 10 nM bPTH-(1-34), similar to the hormone concentration required for 50% receptor occupancy. Activation of protein kinase A or protein kinase C with forskolin or phorbol 12-myristate 13-acetate also increased PTH/PTHrP receptor phosphorylation, but to a lesser degree than PTH. Neither of these kinases mediated the effect of PTH, as blockade of the protein kinase A pathway (with H-89) or the protein kinase C pathway (with the bisindolylmaleimide GF 109203X) did not inhibit bPTH-(1-34)-induced PTH/PTHrP receptor phosphorylation. These results suggest that agonist-stimulated PTH/PTHrP receptor phosphorylation may involve a nonsecond messenger-activated kinase, such as a member of the G protein-coupled receptor kinase family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664644     DOI: 10.1210/endo.136.10.7664644

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases.

Authors:  F Dicker; U Quitterer; R Winstel; K Honold; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism.

Authors:  Marián Castro; Viacheslav O Nikolaev; Dieter Palm; Martin J Lohse; Jean-Pierre Vilardaga
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

3.  Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation.

Authors:  Qiangmin Zhang; Kunhong Xiao; Hongda Liu; Lei Song; Jennifer C McGarvey; W Bruce Sneddon; Alessandro Bisello; Peter A Friedman
Journal:  J Biol Chem       Date:  2018-02-14       Impact factor: 5.157

Review 4.  Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.

Authors:  Jean-Pierre Vilardaga; Guillermo Romero; Peter A Friedman; Thomas J Gardella
Journal:  Cell Mol Life Sci       Date:  2010-08-12       Impact factor: 9.261

5.  IGF-I induced phosphorylation of PTH receptor enhances osteoblast to osteocyte transition.

Authors:  Tao Qiu; Janet L Crane; Liang Xie; Lingling Xian; Hui Xie; Xu Cao
Journal:  Bone Res       Date:  2018-02-26       Impact factor: 13.567

6.  Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling.

Authors:  Diana Zindel; Sandra Engel; Andrew R Bottrill; Jean-Philippe Pin; Laurent Prézeau; Andrew B Tobin; Moritz Bünemann; Cornelius Krasel; Adrian J Butcher
Journal:  Biochem J       Date:  2016-09-13       Impact factor: 3.857

7.  Production and evaluation of parathyroid hormone receptor1 ligands with intrinsic or assembled peroxidase domains.

Authors:  Xavier Charest-Morin; Patrice E Poubelle; François Marceau
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.